From "Life Countdown" to "Tumor Inactive"! Heavy Ion Therapy Rewrites the Fate of a 70-Year-Old Pancreatic Cancer Patient

"When my mother was diagnosed with pancreatic cancer, the doctor said it was locally advanced and she had lost the chance for surgery, leaving only chemotherapy to sustain her life. The thought of this filled me with utter despair. But unexpectedly, heavy ion therapy gave my mother a second chance at life!" the daughter of the septuagenarian grandmother exclaimed with deep emotion. Now, 11 months after her carbon ion treatment, the follow-up results are exhilarating—the once aggressive pancreatic tumor has lost its vitality, with the therapeutic evaluation reaching partial remission (PR)! This remarkable turnaround in her life is a testament to the miraculous power of heavy ion therapy technology.

A septuagenarian faced the "king of cancers," with conventional treatments at a dead end

In January 2024, 72-year-old Grandma Chen was diagnosed with locally advanced pancreatic head and neck adenocarcinoma after seeking medical attention for persistent abdominal pain. Imaging revealed a 7.7×3.5 cm tumor, encasing critical blood vessels like a time bomb， making surgical removal nearly impossible. Even more challenging, her advanced age, combined with hypertension and diabetes, made her unable to tolerate the harsh side effects. Concerned about her condition, her children had no option but to try traditional Chinese medicine, yet her symptoms showed no significant improvement. Faced with the relentless assault of the "king of cancers,"was there truly no way to prevent her life from slipping away?

Carbon ion therapy delivered a precise strike, forcing the tumor to "surrender"

After seeking multiple medical opinions, Grandma Chen arrived at the Radiation Oncology Department VI of Wuwei Heavy Ion Hospital in April 2024. After thorough evaluation, the expert team concluded that carbon ion therapy might break the deadlock. Leveraging the unique "Bragg Peak" property, carbon ion beams function like "precision-guided missiles," concentrating their energy precisely on the tumor site. This approach delivers powerful cancer-killing effects while minimizing damage to surrounding healthy tissues. The treatment process was far more comfortable than expected. Grandma Chen underwent five sessions per week, each lasting just over ten minutes. She experienced no pain, nausea, vomiting, or other discomfort throughout the entire course. After just three weeks of treatment, she was discharged smoothly and quickly resumed her normal life.

​​11-Month Follow-Up: Tumor in "Dormancy" Life Rebooted​

Medical Miracle at 11-Month Follow-Up:​​ Imaging scans revealed dramatic tumor shrinkage with complete loss of metabolic activity, achieving partial remission (PR)! Grandma Chen's abdominal pain vanished completely-her appetite returned, weight increased, and physical stamina fully recovered to pre-illness levels!

​​Comparative Abdominal MRI Findings:​

​​Expert Analysis: How Does Heavy Ion Therapy Achieve a "Game-Changing Breakthrough"?​

Dr. Chen Weizuo, Director of our department, explained:  "Due to pancreatic cancer’s deep-seated location and the complexity of surrounding organs, conventional radiotherapy struggles to target it precisely and often causes severe side effects. Carbon ion therapy, with its high linear energy transfer (LET) properties, induces irreversible DNA damage to cancer cells—particularly effective against hypoxic pancreatic tumors. For patients like Mrs. Chen—who cannot undergo surgery or chemotherapy due to advanced age, comorbidities, or vascular involvement—carbon ion therapy offers a new lifeline." ​​The data confirms its clinical superiority:​​Studies show that for locally advanced pancreatic cancer, carbon ion therapy achieves 1-year survival rates of 60%-70% and local control rates exceeding 80%, significantly outperforming conventional treatments.

Heavy Ion Therapy: Lighting Hope for More Pancreatic Cancer Patients

Mrs. Chen’s case is one of many success stories where heavy ion therapy has effectively treated pancreatic cancer. Our department has successfully treated hundreds of cancer patients with precision heavy ion therapy, including challenging cases such as pancreatic cancer, liver cancer, lung cancer, prostate cancer, bladder cancer, and colorectal cancer.

If you or a loved one is fighting cancer—particularly those who cannot undergo surgery or chemotherapy—consider heavy ion therapy as a potential option. It could be a game-changing treatment, offering both extended survival and improved quality of life. Let heavy ion therapy be your path to hope and healing.

Heavy Ion Therapy for Pancreatic & Abdominopelvic Cancers

●Department overview

Department of Radiation Oncology VI is a specialized center for heavy ion therapy of pancreatic cancer and abdominopelvic tumors, focusing on heavy ion treatment for pancreatic cancer as well as heavy ion and photon radiotherapy for abdominopelvic malignancies including liver cancer, colorectal cancer, and prostate cancer. Since its establishment, pancreatic cancer patients from across China have sought treatment here, where tumors can be precisely eradicated without pain, surgery, or tissue damage. The department has successfully treated dozens of pancreatic cancer patients nationwide, achieving over 90% one-year local control rate and extending median survival time from the conventional 11 months to 19 months. With demonstrated efficacy, excellent patient experience, and remarkable therapeutic outcomes, the treatment has gained full recognition from renowned domestic and international experts as well as numerous patients.

●Professional team

All team members graduated from prestigious medical universities in China, possessing solid medical theoretical foundations and extensive clinical experience. The department has specially appointed renowned experts including Professor Hoffe from Germany, Professor Tsujii Hirohiko from Japan, and Professors Yee-Min Jen and Jia-Ming Wu from Taiwan to provide guidance, conduct consultations for complex cases, deliver academic lectures, and participate in ward rounds. The medical staff have completed advanced training programs at several leading heavy ion and photon therapy centers across China, accumulating substantial experience in heavy ion treatment. This enables them to develop scientifically sound and personalized treatment plans for patients.

●Treatment scope

The department focuses on heavy ion treatment for pancreatic cancer, and also carries out heavy ion and photon treatments for abdominal and pelvic tumors such as liver cancer, colorectal cancer, and prostate cancer, providing patients with professional radiotherapy and personalized comprehensive cancer treatment services.

Department Specialist Introduction:

Chen Weizuo

Director of Department of Radiation Oncology VI, Heavy Ion Center, Gansu Wuwei Cancer Hospital, Associate Chief Physician

Gansu Provincial "Loyuan Youth Elite" Awardee

Member of the Brachytherapy and Intelligent Radiotherapy Branch, Chinese Nuclear Society

Committee Member of the Youth Branch, Western Radiation Therapy Association

Member of the Ion Radiotherapy Branch, China Association of Medical Equipment

Member of the Youth Committee for Radioimmunotherapy, CRTOG

Youth Committee Member of the Gastric Cancer/Colorectal Cancer Professional Committee, Gansu Anti-Cancer Association

Committee Member of the Radiotherapy Professional Committee, Wuwei Medical Association

Principal Investigator:

   • 1 "Western Light" Talent Training Program project by Chinese Academy of Sciences

   • 2 "Loyuan Youth Innovation and Entrepreneurship" talent projects by Gansu Provincial Organization Department

Publications and Patents:

   • 11 SCI-indexed papers

   • 5 Chinese core journal articles

   • 2 national invention patents

   • 3 utility model patents

   • Gold Medal at the "National Invention Exhibition" for patented invention

Yin Chaosheng

Member of the Communist Party of China

Former Director of Radiation Oncology Department, Xiangnan University Affiliated Hospital (Hunan Province)

Standing Committee Member, Chenzhou Medical Association Oncology Professional Committee

Standing Committee Member, Chenzhou Anti-Cancer Association

Committee Member, Hunan International Medical Exchange Association for Radiation Oncology and Radioimmunotherapy

Committee Member, Hunan Medical Education and Technology Association Clinical Nutrition Professional Committee

With over 18 years of clinical experience in cancer treatment

Trained under:

   • Professor Yee-Min Jen, Former Chairman of Radiation Oncology Society, Taiwan region of China

   • Professor Wang Jinzhu, Medical Management Expert, Tzu Chi Hospital, Taiwan region of China

Visiting Scholar at:

   • Tri-Service General Hospital, Taiwan region of China

   • Chang Gung Memorial Hospital, Taiwan region of China

Specializations:

   • Precision radiation therapy

   • Stereotactic radiotherapy

   • Comprehensive treatment of head and neck cancers